Showing 231-240 of 796 results for "".
Practical Considerations for Treating Psoriasis: Focus on Secukinumab
https://practicaldermatology.com/topics/psoriasis/practical-considerations-for-treating-psoriasis-focus-on-secukinumab/20841/West Meets East and Osteopathic Manipulative Medicine: Combining Treatment Modalities for Atopic Dermatitis
https://practicaldermatology.com/topics/general-topics/west-meets-east-and-osteopathic-manipulative-medicine-combining-treatment-modalities-for-atopic-dermatitis/20894/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/23510/Why Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?A Brief History of Nail Cosmetics
https://practicaldermatology.com/topics/hair-nails/a-brief-history-of-nail-cosmetics/23871/A dermatologist’s guide to the risks of newer nail cosmetics.Retaliation Rules ... Without Rules
https://practicaldermatology.com/topics/editorial/retaliation-rules-without-rules/26653/Practical Dermatology Chief Medical Editor and dermatologist Neal Bhatia, MD, FAAD, reflects on the dynamics of medical board complaints, their impact on careers, and what pracitioners need to keep in mind when dealing with challenges.2020 Year-End Tax Tips
https://practicaldermatology.com/topics/practice-management/2020-year-end-tax-tips/23392/Plan for the current year and preview possible changes ahead.Currents
https://practicaldermatology.com/topics/practice-management/currents-4/23055/DermWireTV: AcneAlly Launches, Rosacea Insights, MC2/EPI Collaboration
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-acneally-launches-rosacea-insights-mc2epi-collaboration/19849/Dennis Porto, MD and Riyaz Farhaad, MD have launched AcneAlly.com, an online service that allows patients access to a board certified dermatologist and a standardized approach to assessment and long-term monitoring. Julie Harper, MD discusses findings from “Beyond the visible: Rosacea and psoriasisGalderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million d